Andrew Cridland

Andrew Cridland has a strong background in medicinal chemistry and pharmaceutical research. With experience in various renowned companies like Charles River Laboratories, Eisai US, GSK, and AstraZeneca, Andrew has held roles ranging from Scientist to Team Leader to Principal Scientist. Known for their strategic approach in setting medicinal chemistry strategies and managing cross-site projects, Andrew has successfully delivered multiple clinical candidates. Andrew also has a PhD in Organic Chemistry from the University of Nottingham.